137 related articles for article (PubMed ID: 2789462)
1. Insulin binding substances, autoimmunity and type I diabetes in Kuwaiti patients and their kindred.
Richens ER; Shaltout A; Bahr GM; Abdella N; Jayyab AK; Al-Saffar M; Behbehani K
Acta Diabetol Lat; 1989; 26(2):115-22. PubMed ID: 2789462
[TBL] [Abstract][Full Text] [Related]
2. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
[TBL] [Abstract][Full Text] [Related]
3. Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes.
Ziegler R; Alper CA; Awdeh ZL; Castano L; Brink SJ; Soeldner JS; Jackson RA; Eisenbarth GS
Diabetes; 1991 Jun; 40(6):709-14. PubMed ID: 2040387
[TBL] [Abstract][Full Text] [Related]
4. HLA-associated insulin autoantibody formation in newly diagnosed type I diabetic patients.
Ziegler AG; Standl E; Albert E; Mehnert H
Diabetes; 1991 Sep; 40(9):1146-9. PubMed ID: 1936622
[TBL] [Abstract][Full Text] [Related]
5. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes.
Li H; Lindholm E; Almgren P; Gustafsson A; Forsblom C; Groop L; Tuomi T
J Clin Endocrinol Metab; 2001 Feb; 86(2):574-82. PubMed ID: 11158011
[TBL] [Abstract][Full Text] [Related]
6. Type 2 diabetes in Arab patients in Kuwait.
Richens ER; Abdella N; Jayyab AK; al-Saffar M; Behbehani K
Diabet Med; 1988 Apr; 5(3):231-4. PubMed ID: 2967143
[TBL] [Abstract][Full Text] [Related]
7. HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study.
Rich SS; French LR; Sprafka JM; Clements JP; Goetz FC
Diabetologia; 1993 Mar; 36(3):234-8. PubMed ID: 8462772
[TBL] [Abstract][Full Text] [Related]
8. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects.
Dubois-Laforgue D; Timsit J; Djilali-Saiah I; Boitard C; Caillat-Zucman S
Hum Immunol; 1997 Oct; 57(2):104-9. PubMed ID: 9438201
[TBL] [Abstract][Full Text] [Related]
9. [Insulin autoantibody].
Uchigata Y
Nihon Rinsho; 1997 Nov; 55 Suppl():333-8. PubMed ID: 9434490
[No Abstract] [Full Text] [Related]
10. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
11. Aggregation of subclinical autonomic nervous system dysfunction and autoantibodies in families with type I diabetes.
Brown FM; Watts M; Rabinowe SL
Diabetes; 1991 Dec; 40(12):1611-4. PubMed ID: 1756901
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.
Kuglin B; Bertrams J; Linke C; Gries FA; Kolb H
Klin Wochenschr; 1989 Jan; 67(2):66-73. PubMed ID: 2646470
[TBL] [Abstract][Full Text] [Related]
13. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
[TBL] [Abstract][Full Text] [Related]
14. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
15. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.
Deschamps I; Boitard C; Hors J; Busson M; Marcelli-Barge A; Mogenet A; Robert JJ
Diabetologia; 1992 Oct; 35(10):951-7. PubMed ID: 1451952
[TBL] [Abstract][Full Text] [Related]
16. Thyrogastric autoimmunity and MHC associated alleles at the C4 locus in patients with type 1 (insulin-dependent) diabetes.
McCann VJ; McCluskey J; Kelly H; Kay PH; Zilko PJ; Christiansen FT; Dawkins RL
Diabetologia; 1984 Jul; 27 Suppl():124-5. PubMed ID: 6332753
[TBL] [Abstract][Full Text] [Related]
17. Anti-insulin antibodies in children with type I diabetes mellitus. Genetic regulation of production and presence at diagnosis before insulin replacement.
McEvoy RC; Witt ME; Ginsberg-Fellner F; Rubinstein P
Diabetes; 1986 Jun; 35(6):634-41. PubMed ID: 3519320
[TBL] [Abstract][Full Text] [Related]
18. Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failure.
Zavala AV; Fabiano de Bruno LE; Cardoso AI; Mota AH; Capucchio M; Poskus E; Fainboim L; Basabe JC
Diabetologia; 1992 Dec; 35(12):1159-64. PubMed ID: 1478368
[TBL] [Abstract][Full Text] [Related]
19. Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.
Thivolet C; Beaufrére B; Bétuel H; Gebuhrer L; Chatelain P; Durand A; Tourniaire J; François R
Diabetologia; 1988 Oct; 31(10):741-6. PubMed ID: 3071483
[TBL] [Abstract][Full Text] [Related]
20. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
